Federal Ministry of Economics supports the university and a spin-off with 3.6 million euros.
Starting this month, the German Federal Ministry of Economic Affairs and Climate Action is funding a joint project to research efficient and safe special lipids for mRNA drugs with a two-digit million euro sum for three years. Partners in the research alliance are the universities of Jena, Würzburg and Dortmund, the start-up company NGP Polymers in Jena, and the companies Bayer, Evonik and ISAR Bioscience.
Since the Corona pandemic, the usefulness of ribonucleic acids (RNA) or messenger RNA (mRNA) for the production of highly effective vaccines has been undisputed. Now the partners from industry and science want to investigate whether other new drugs can also be developed on this basis, as well as whether the few allergic reactions associated with vaccinations can be reduced.